Insider Transactions in Q4 2025 at Mineralys Therapeutics, Inc. (MLYS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2025
|
Jon Congleton Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,082
+3.54%
|
$0
$0.54 P/Share
|
|
Nov 20
2025
|
Brian Taylor Slingsby Director |
SELL
Open market or private sale
|
Indirect |
1,000,000
-11.23%
|
$43,000,000
$43.35 P/Share
|
|
Nov 13
2025
|
Alexander M Gold Director |
SELL
Open market or private sale
|
Direct |
12,742
-100.0%
|
$586,132
$46.5 P/Share
|
|
Nov 13
2025
|
Alexander M Gold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,742
+46.99%
|
$140,162
$11.45 P/Share
|
|
Nov 13
2025
|
Daphne Karydas Director |
SELL
Open market or private sale
|
Direct |
15,000
-83.72%
|
$690,000
$46.09 P/Share
|
|
Nov 13
2025
|
Daphne Karydas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$150,000
$10.2 P/Share
|
|
Nov 12
2025
|
Alexander M Gold Director |
SELL
Open market or private sale
|
Direct |
6,933
-86.06%
|
$318,918
$46.89 P/Share
|
|
Nov 12
2025
|
Alexander M Gold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,933
+50.0%
|
$69,330
$10.2 P/Share
|
|
Nov 11
2025
|
Alexander M Gold Director |
SELL
Open market or private sale
|
Direct |
15,000
-83.33%
|
$660,000
$44.76 P/Share
|
|
Nov 11
2025
|
Alexander M Gold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$150,000
$10.2 P/Share
|
|
Nov 11
2025
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
200,000
-4.36%
|
$8,800,000
$44.23 P/Share
|
|
Nov 11
2025
|
Adam Scott Levy CFO and Secretary |
SELL
Open market or private sale
|
Direct |
119,524
-16.23%
|
$5,139,532
$43.56 P/Share
|
|
Nov 11
2025
|
Adam Scott Levy CFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
105,653
+21.31%
|
$1,373,489
$13.97 P/Share
|
|
Oct 15
2025
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,369
-12.72%
|
$445,867
$43.01 P/Share
|
|
Oct 13
2025
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,100
-0.89%
|
$634,200
$42.83 P/Share
|
|
Oct 13
2025
|
Adam Scott Levy CFO and Secretary |
SELL
Open market or private sale
|
Direct |
10,758
-4.3%
|
$451,836
$42.08 P/Share
|